Name:	tffp_AgreementTremDescription
Namespace Prefix:	tffp_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Percentage of common stock outstanding shares.

No definition available.

Name:	tffp_CommonStockOutstandingPercentage
Namespace Prefix:	tffp_
Data Type:	dtr:percentItemType
Balance Type:	na
Period Type:	duration

Interst fee.

No definition available.

Name:	tffp_InterstFee
Namespace Prefix:	tffp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- References

No definition available.

Name:	tffp_LicenseandAgreementsDetailsLineItems
Namespace Prefix:	tffp_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Milestone fee.

No definition available.

Name:	tffp_MilestoneFee
Namespace Prefix:	tffp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- References

No definition available.

Name:	tffp_PremarketingApprovals
Namespace Prefix:	tffp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Recorded receivable.

No definition available.

Name:	tffp_RecordedReceivable
Namespace Prefix:	tffp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Research and development expense.

No definition available.

Name:	tffp_ResearchAndDevelopmentExpenses
Namespace Prefix:	tffp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.15(a))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(5))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Name:	us-gaap_AccountsPayableCurrentAndNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Amount of the fee that accompanies borrowing money under the debt instrument.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(b))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Name:	us-gaap_DebtInstrumentFeeAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

The cash outflow for cost incurred directly with the issuance of an equity security.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585

Name:	us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 912
-SubTopic 730
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Name:	tffp_AgreementAxis=tffp_MasterServicesAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_ProductOrServiceAxis=tffp_ContractManufacturingServicesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	tffp_AgreementAxis=tffp_MasterConsultancyAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	tffp_AgreementAxis=tffp_ClinicalTrialResearchAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	tffp_AgreementAxis=tffp_TrialResearchAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tffp_ClinicalNetworkServicesPtyLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: